SI-BONE, Inc. (NASDAQ:SIBN) Insider Sells $49,606.20 in Stock

SI-BONE, Inc. (NASDAQ:SIBNGet Free Report) insider Anthony J. Recupero sold 3,937 shares of SI-BONE stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $12.60, for a total value of $49,606.20. Following the completion of the sale, the insider now owns 228,554 shares of the company’s stock, valued at $2,879,780.40. The trade was a 1.69 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

SI-BONE Stock Up 2.2 %

Shares of NASDAQ:SIBN opened at $12.56 on Friday. SI-BONE, Inc. has a 1 year low of $11.70 and a 1 year high of $21.70. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22. The business’s 50-day moving average is $13.72 and its 200 day moving average is $14.22.

Wall Street Analyst Weigh In

Several research firms have recently commented on SIBN. Truist Financial boosted their price target on shares of SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. Needham & Company LLC reissued a “buy” rating and issued a $19.00 price objective on shares of SI-BONE in a research note on Wednesday. Finally, Morgan Stanley lowered their target price on SI-BONE from $21.00 to $19.00 and set an “overweight” rating for the company in a report on Tuesday, August 6th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $23.00.

Get Our Latest Stock Analysis on SI-BONE

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. FMR LLC increased its holdings in shares of SI-BONE by 103.6% in the third quarter. FMR LLC now owns 2,354 shares of the company’s stock valued at $33,000 after purchasing an additional 1,198 shares during the period. Canada Pension Plan Investment Board acquired a new stake in SI-BONE during the 2nd quarter valued at approximately $61,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of SI-BONE by 24.7% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,649 shares of the company’s stock valued at $138,000 after acquiring an additional 2,108 shares during the last quarter. Arizona State Retirement System increased its stake in shares of SI-BONE by 9.0% in the second quarter. Arizona State Retirement System now owns 10,921 shares of the company’s stock worth $141,000 after acquiring an additional 903 shares during the period. Finally, Walleye Capital LLC purchased a new position in shares of SI-BONE during the third quarter worth $144,000. Institutional investors and hedge funds own 98.11% of the company’s stock.

About SI-BONE

(Get Free Report)

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.

Featured Stories

Insider Buying and Selling by Quarter for SI-BONE (NASDAQ:SIBN)

Receive News & Ratings for SI-BONE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-BONE and related companies with MarketBeat.com's FREE daily email newsletter.